Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper (II) complexes containing gluconate
DH Cai, CL Zhang, QY Liu, L He, YJ Liu… - European Journal of …, 2021 - Elsevier
In this paper, two new Cu (II) complexes,[Cu (Gluc)(HPB)(H 2 O)] Gluc (CuG1) and [Cu
(Gluc)(HPBC)(H 2 O)] Gluc (CuG2)(where HPB= 2-(2′-pyridyl) benzimidazole, HPBC= 5 …
(Gluc)(HPBC)(H 2 O)] Gluc (CuG2)(where HPB= 2-(2′-pyridyl) benzimidazole, HPBC= 5 …
Dehydroacetic acid a privileged medicinal scaffold: A concise review
From the last decade, research on dehydroacetic acid (DHA) and its derivatives has
increased immensely due to its significant role in various fields, including medicine …
increased immensely due to its significant role in various fields, including medicine …
Facile synthesis and deliberate characterization for new hydrazide complexes; cyclic voltammetry, crystal packing, eukaryotic DNA degradation and in-silico studies
New metal ion complexes were synthesized from new NO donor hydrazide ligand derived
from acid hydrazide. All new synthesizes were investigated by all available analytical …
from acid hydrazide. All new synthesizes were investigated by all available analytical …
A novel water-soluble Cu (II) gluconate complex inhibits cancer cell growth by triggering apoptosis and ferroptosis related mechanisms
DH Cai, BF Liang, BH Chen, QY Liu, ZY Pan… - Journal of Inorganic …, 2023 - Elsevier
Metal copper complexes have attracted extensive attention as potential alternatives to
platinum-based anticancer drugs due to their possible different modes of action. Herein, a …
platinum-based anticancer drugs due to their possible different modes of action. Herein, a …
A novel bidentate ligand containing oxime, hydrazone and indole moieties and its BF2+ bridged transition metal complexes and their efficiency against prostate and …
In this study, a novel bidentate ligand containing oxime, hydrazone, and indole moieties and
its BF2+‐bridged transition metal complexes [Ni (II), Cu (II), and Co (II)] were synthesized …
its BF2+‐bridged transition metal complexes [Ni (II), Cu (II), and Co (II)] were synthesized …
Exploring the DNA binding efficacy of Cobalt (II) and Copper (II) complexes of hydroxamic acids and explicating their anti-cancer propensity
Y Thakur, R Agrawal, M Tripathi, MK Siddiqi… - Journal of Molecular …, 2019 - Elsevier
Calf-thymus DNA (ct-DNA) binding efficacy of Bis (Np-tolylbenzohydroxamato) Cobalt
(II),[Np-TBHA-Co (II)] and Bis (Np-naphthylbenzohydroxamato) Copper (II),[Np-NBHA-Cu (II)] …
(II),[Np-TBHA-Co (II)] and Bis (Np-naphthylbenzohydroxamato) Copper (II),[Np-NBHA-Cu (II)] …
Synthesis and characterization of a mononuclear nickel (II) complex with N, O-donor ligand: Its DNA/HSA protein binding properties and tumor suppressive function
A mononuclear Ni (II) complex,([Ni (HL) 2] Cl 2• H 2 O)(Complex 1), where HL= 1-((2-
piperidin-1-yl) ethylimino) methyl) naphthalene-2-ol has been synthesized under mild …
piperidin-1-yl) ethylimino) methyl) naphthalene-2-ol has been synthesized under mild …
New aroyl heterocyclic (E)-N′-((2-hydroxynaphthalen-1-yl)methylene)-4-oxopiperidine-1-carbohydrazide and its metal complexes: synthesis, spectroscopic …
G Dongare, A Aswar - Research on Chemical Intermediates, 2024 - Springer
In order to resist the growth of human pathogenic microorganisms, a new N-heterocyclic
ligand of (E)-N′-((2-hydroxynaphthalen-1-yl) methylene)-4-oxopiperidine-1 …
ligand of (E)-N′-((2-hydroxynaphthalen-1-yl) methylene)-4-oxopiperidine-1 …
Design, Synthesis and Biological Evaluation of Novel Gypsogenin Derivatives as Potential Anticancer and Antimicrobial Agents
Natural compounds are important sources for the treatment of chronic disorders such as
cancer and microbial infectious disorders. In this research, Gypsogenin and its derivatives (2 …
cancer and microbial infectious disorders. In this research, Gypsogenin and its derivatives (2 …
Anticancer and antimicrobial activities of a novel 4-nitrobenzohydrazone and the Cu (II), Ni (II), Co (II), and Mn (II) complexes
Antimicrobial and anticancer activities against prostate (PC-3) and breast (MCF-7) cancer
cells by Schiff base derived from novel 4-Nitrobenzohydrazone ligand and its Cu (II), Ni (II) …
cells by Schiff base derived from novel 4-Nitrobenzohydrazone ligand and its Cu (II), Ni (II) …